| Product Code: ETC7652870 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel HER2 Positive Breast Cancer Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel HER2 Positive Breast Cancer Treatment Market - Industry Life Cycle |
3.4 Israel HER2 Positive Breast Cancer Treatment Market - Porter's Five Forces |
3.5 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel HER2 Positive Breast Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HER2 positive breast cancer in Israel |
4.2.2 Technological advancements in HER2 positive breast cancer treatment options |
4.2.3 Growing investments in research and development for innovative treatments |
4.3 Market Restraints |
4.3.1 High treatment costs associated with HER2 positive breast cancer therapies |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Israel |
4.3.3 Stringent regulatory requirements for approval of new treatments |
5 Israel HER2 Positive Breast Cancer Treatment Market Trends |
6 Israel HER2 Positive Breast Cancer Treatment Market, By Types |
6.1 Israel HER2 Positive Breast Cancer Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.4 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.6 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel HER2 Positive Breast Cancer Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 Israel HER2 Positive Breast Cancer Treatment Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel HER2 Positive Breast Cancer Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Israel HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel HER2 Positive Breast Cancer Treatment Market Import-Export Trade Statistics |
7.1 Israel HER2 Positive Breast Cancer Treatment Market Export to Major Countries |
7.2 Israel HER2 Positive Breast Cancer Treatment Market Imports from Major Countries |
8 Israel HER2 Positive Breast Cancer Treatment Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of targeted therapies for HER2 positive breast cancer |
8.3 Percentage of patients receiving timely diagnosis and treatment |
8.4 Rate of participation in clinical trials for new HER2 positive breast cancer treatments |
8.5 Patient satisfaction with the quality of care and support services |
9 Israel HER2 Positive Breast Cancer Treatment Market - Opportunity Assessment |
9.1 Israel HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Israel HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Israel HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Israel HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel HER2 Positive Breast Cancer Treatment Market - Competitive Landscape |
10.1 Israel HER2 Positive Breast Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel HER2 Positive Breast Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here